← Leaderboards
Susanna Curtis
Albert Einstein College Of Medicine
$967,288
Attributed
$967,288
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $194.2K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$967,288 · 1
By mechanism
K23$967,288 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Elena Zotova$451,455
- Subhrajit Saha$8,338,697
Others in their field
Other Emerging Leaders on “Cytokine”
- Thomas Denny · Duke University$22,999,550
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
- Gary Fanger · Rise Therapeutics, Llc$12,156,047
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$9,841,960
Research focus
CytokineAdultAdverse EffectsAnti-Inflammatory AgentsAnxietyAdverse EventAdvisory CommitteesCannabinoid TreatmentCannabisCapsuleCareerCareer DevelopmentBenefits And RisksChronic PainCannabinoidsClinical InvestigatorClinical ResearchClinical Trial AnalysisClinical TrialsClinical Trials DesignCognitive FunctionControlled StudyCross-Sectional StudiesData Analyses
Grant awards (5)
Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease$193,276
K23 · FY2025 · HL · contact PI
Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease$193,276
K23 · FY2024 · HL · contact PI
Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease$193,276
K23 · FY2023 · HL · contact PI
Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease$193,276
K23 · FY2022 · HL · contact PI
Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease$194,184
K23 · FY2021 · HL · contact PI